Background & Aims: In patients with nephrotic syndrome, the natriuretic effect of furosemide (FU) is diminished. The effect of co administration of FU and human albumin (HA) has remained controversial.Material & Methods: In a cross-over clinical trial study, ten nephrotic patients (seven females, 33.57years) on standardized sodium chloride intake, in random order on three separate days, received by intravenous administration for 60 minutes either (a) 1 mg/kg FU plus a sham infusion, (b) 1mg/kg FU plus 200 ml of a 20% solution of HA, or (c) sham infusion plus 200 ml of a 20% solution of HA. Urinary volume and sodium excretion and glomerular filtration rate were assessed. Results: Mean 24h urine volume after infusion of HA, FU, and HA plus FU was 724ml (SD= 528), 1707ml (SD=745), 2175ml (SD=971), respectively (Pv=0.015). Mean FENa was 1.96% (SD=0.251), 3.18% (SD=0.25), 4.77% (SD=0.21) respectively, (Pv=0.015). Mean 24h urine Na was 118.3 (SD=6.86), 208.4 (SD=5.27), 206 (SD=8.45) respectively, (Pv=0.005). Mean GFR was 104.5, 96.6, 106.6 respectively, (Pv=0.021).Conclusion: Coadministration of HA potentates the action of FU in patients with nephrotic syndrome by increasing effects on GFR and diuretic potency of FU.